NCT06256562View on ClinicalTrials.gov

A Study of GZR18 Injection in Obese/Overweight Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

340

Participants

Timeline

Start Date

June 8, 2023

Primary Completion Date

June 5, 2024

Study Completion Date

June 5, 2024

Conditions
ObesityOverweight
Interventions
DRUG

GZR18

Titrated to dose 1, dose 2, dose 3 or dose 4

OTHER

Placebo

Administered the same volume as GZR18

Trial Locations (1)

Unknown

Gan & Lee Pharmaceuticals Co., Ltd, Beijing

Sponsors
All Listed Sponsors
lead

Gan and Lee Pharmaceuticals, USA

INDUSTRY